Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients

Current Medical Research and Opinion

Volumn 25, Issue 9, 2009, Pages 2271-2280

  Mourad, Jean Jacques ^a   Le Jeune, S ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

Blood pressure reduction; Cardiovascular protection; Perindopril indapamide fixed combination; Renal protection

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ATENOLOL; INDAPAMIDE PLUS PERINDOPRIL; PLACEBO; POTASSIUM;

ALBUMIN BLOOD LEVEL; ALBUMINURIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COUGHING; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DOSE CALCULATION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; GLUCOSE BLOOD LEVEL; HEADACHE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; KIDNEY DISEASE; MAXIMUM PERMISSIBLE DOSE; MORBIDITY; MORTALITY; NOTE; POTASSIUM BLOOD LEVEL; PROTEIN METABOLISM; RENAL PROTECTION; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; URINARY TRACT INFECTION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HUMANS; HYPERTENSION; INDAPAMIDE; KIDNEY; KIDNEY DISEASES; PERINDOPRIL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TITRIMETRY; TREATMENT OUTCOME;

EID: 69849086485     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903186787     Document Type: Note

References (26)

1. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187 (Pubitemid 46924065)
2. Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-878 (Pubitemid 34940826)
3. Dahlöf B, Gosse P, Gueret P, et al. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens 2005;23:2063-2070 (Pubitemid 41830403)
4. Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003 (Pubitemid 34286536)
5. Mourad JJ, Waeber B, Zannad F, et al. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. J Hypertens 2004;22:2379-2386 (Pubitemid 39620288)
6. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOTBPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906 (Pubitemid 41265663)
7. Kjeldsen SE, Naditch-Brule L, Perlini S, et al. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens 2008;26:2064-2070
8. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053 (Pubitemid 36667855)
9. Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-840 (Pubitemid 47362321)
10. Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008;26:1505-1526
11. Mallion JM, Chamontin B, Asmar R, et al. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/ indapamide first-line combination in hypertensive patients: the REASON study. Am J Hypertens 2004;17:245-251 (Pubitemid 38293330)
12. Mogensen CE, Viberti G, Halimi S, et al. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension 2003;41:1063-1071 (Pubitemid 36548604)
13. Chalmers J, Joshi R, Kengne AP, MacMahon S. Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE. J Hypertens Suppl 2008;26:S11-15
14. ADVANCE - Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline. Diabet Med 2005;22:882-888
15. Neglia D, Fommei E, Ghione S, et al. P727: coronary microvascular dysfunction in hypertensive patients with left ventricular hypertrophy can be reversed by treatment with a fixed combination of perindropril and indapamide. Eur Heart J 2008;29(Abstr Suppl):103
16. Mourad JJ, Hanon O, Deverre JR, et al. Improvement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: a pilot PET study. J Renin Angiotensin Aldosterone Syst 2003;4:94-95 (Pubitemid 36790179)
17. Asmar RG, London GM, O'Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001;38:922-926
18. de Galan B, Perkovic V, Ninomiya T, et al. Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol 2009;20:883-892
19. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-1898 (Pubitemid 351620109)
20. Myers MG, Asmar R, Leenen FH, et al. Fixed low-dose combination therapy in hypertension - a dose response study of perindopril and indapamide. J Hypertens 2000;18:317-325 (Pubitemid 30142849)
21. Mourad JJ, Le Jeune S. High dose of perindopril/indapamide (8/2.5mg) fixed combination is more effective in reducing blood pressure and left ventricular hypertrophy in hypertensive patients. In: European Society of Hypertension 2009, June 12-16; Milan, Italy
22. Gosse P. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection. Expert Rev Cardiovasc Ther 2006;4:319-333 (Pubitemid 43796990)
23. Kang S, Wu YF, An N, et al. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension. Clin Ther 2004;26:257-270
24. BI PRETERAX® 4mg/1.5mg tablet. European summary of product characteristics. Servier International, Neuilly sur Seine, France. 11/2002
25. PRETERAX® 2mg/0.625mg tablet. European summary of product characteristics. Servier International, Neuilly sur Seine, France. 11/2003
26. Zillich J, Garg J, Basu S. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006;48:219-224 (Pubitemid 44309815)